ZA201408333B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA201408333B ZA201408333B ZA2014/08333A ZA201408333A ZA201408333B ZA 201408333 B ZA201408333 B ZA 201408333B ZA 2014/08333 A ZA2014/08333 A ZA 2014/08333A ZA 201408333 A ZA201408333 A ZA 201408333A ZA 201408333 B ZA201408333 B ZA 201408333B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3583MU2013 IN2013MU03583A (instruction) | 2013-11-14 | 2014-11-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201408333B true ZA201408333B (en) | 2015-12-23 |
Family
ID=51947385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/08333A ZA201408333B (en) | 2013-11-14 | 2014-11-13 | Pharmaceutical compositions |
Country Status (3)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03583A (instruction) |
| WO (1) | WO2015071668A1 (instruction) |
| ZA (1) | ZA201408333B (instruction) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3967312A1 (en) | 2014-09-12 | 2022-03-16 | UNION therapeutics A/S | Antibacterial use of halogenated salicylanilides |
| GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
| EP3496714A4 (en) | 2016-08-11 | 2020-04-22 | Adamis Pharmaceuticals Corporation | DRUG COMPOSITIONS. |
| CN106420782B (zh) * | 2016-11-24 | 2019-01-18 | 成都乾坤动物药业股份有限公司 | 一种阿维菌素分散片及其制备方法 |
| WO2018104150A1 (en) * | 2016-12-09 | 2018-06-14 | Bayer Animal Health Gmbh | Pharmaceutical preparation and method for its manufacture |
| EP3720844A4 (en) | 2017-12-08 | 2021-08-11 | Adamis Pharmaceuticals Corporation | MEDICINAL COMPOSITIONS |
| US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
| RU2722272C1 (ru) * | 2019-04-30 | 2020-05-28 | Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" | Средство для лечения и профилактики нематодозов и цестодозов у мелких домашних животных |
| US20220047506A1 (en) * | 2020-08-12 | 2022-02-17 | Villya LLC | Praziquantel Formulations |
| WO2023272362A1 (en) * | 2021-07-01 | 2023-01-05 | The University Of Western Australia | Fish feed additives |
| CN115869275B (zh) * | 2022-12-27 | 2024-10-29 | 佛山市南海东方澳龙制药有限公司 | 一种动物用驱虫片及其制备方法 |
| CN115844843B (zh) * | 2022-12-27 | 2024-10-29 | 佛山市南海东方澳龙制药有限公司 | 多单元分散的驱虫片及其制备方法 |
| WO2024158694A1 (en) | 2023-01-23 | 2024-08-02 | Villya LLC | Compositions and methods for improving the solubility of erectile dysfunction therapeutics |
| CN117771188A (zh) * | 2023-12-25 | 2024-03-29 | 中原食品实验室 | 一种含阿苯达唑与伊维菌素的预混剂及其制备方法 |
| CN119345131A (zh) * | 2024-10-16 | 2025-01-24 | 郑州大学 | 一种吡喹酮可溶性粉或者液体制剂的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0922302B8 (pt) * | 2008-12-05 | 2021-05-25 | Bayer Animal Health Gmbh | extrudados com substâncias ativas aciculares, seu uso, e medicamentos |
| HU231017B1 (hu) * | 2012-05-08 | 2019-11-28 | LAVET Gyógyszeripari Kft. | Praziquantel tartalmú ízfedett formulációk |
-
2014
- 2014-11-13 WO PCT/GB2014/053366 patent/WO2015071668A1/en active Application Filing
- 2014-11-13 ZA ZA2014/08333A patent/ZA201408333B/en unknown
- 2014-11-13 IN IN3583MU2013 patent/IN2013MU03583A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2013MU03583A (instruction) | 2015-07-31 |
| WO2015071668A1 (en) | 2015-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288961A (en) | Pharmaceutical preparations | |
| SMT201900684T1 (it) | Composizione farmaceutica combinata | |
| PL2943181T3 (pl) | Kompozycje farmaceutyczne | |
| GB201304662D0 (en) | Compositions | |
| ZA201408333B (en) | Pharmaceutical compositions | |
| PL3043778T3 (pl) | Kompozycje farmaceutyczne zawierające refametinib | |
| GB201608461D0 (en) | Compositions | |
| IL241254A0 (en) | Pharmaceutical preparations containing everolimus | |
| EP3003324A4 (en) | Pharmaceutical compositions | |
| SG11201601477VA (en) | Pharmaceutical composition | |
| SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
| IL242704B (en) | Pharmacy preparation | |
| GB201320962D0 (en) | Compositions | |
| ZA201506637B (en) | Micronized pharmaceutical compositions | |
| ZA201601645B (en) | Bendamustine pharmaceutical compositions | |
| HUP1300496A2 (hu) | Stabil kombinációs gyógyszerkészítmény | |
| IL244365A0 (en) | pharmaceutical preparation | |
| AP2015008890A0 (en) | Pharmaceutical compositions | |
| GB201304699D0 (en) | Pharmaceutical compositions | |
| GB201320959D0 (en) | Compositions | |
| GB201321497D0 (en) | Pharmaceutical compositions | |
| GB201312851D0 (en) | Pharmaceutical compositions | |
| GB201304625D0 (en) | New pharmaceutical composition | |
| GB201316662D0 (en) | Pharmaceutical Combination | |
| GB201312224D0 (en) | Compositions |